These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 24746933

  • 21. CSF tau, Aβ42, and MHPG differentiate dementia with Lewy bodies from Alzheimer's disease.
    Aerts MB, Esselink RA, Claassen JA, Abdo WF, Bloem BR, Verbeek MM.
    J Alzheimers Dis; 2011; 27(2):377-84. PubMed ID: 21841257
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Longitudinal study of cerebrospinal fluid levels of tau, A beta1-40, and A beta1-42(43) in Alzheimer's disease: a study in Japan.
    Kanai M, Matsubara E, Isoe K, Urakami K, Nakashima K, Arai H, Sasaki H, Abe K, Iwatsubo T, Kosaka T, Watanabe M, Tomidokoro Y, Shizuka M, Mizushima K, Nakamura T, Igeta Y, Ikeda Y, Amari M, Kawarabayashi T, Ishiguro K, Harigaya Y, Wakabayashi K, Okamoto K, Hirai S, Shoji M.
    Ann Neurol; 1998 Jul; 44(1):17-26. PubMed ID: 9667589
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. The AD-CSF-index discriminates Alzheimer's disease patients from healthy controls: a validation study.
    Molinuevo JL, Gispert JD, Dubois B, Heneka MT, Lleo A, Engelborghs S, Pujol J, de Souza LC, Alcolea D, Jessen F, Sarazin M, Lamari F, Balasa M, Antonell A, Rami L.
    J Alzheimers Dis; 2013 Jul; 36(1):67-77. PubMed ID: 23524657
    [Abstract] [Full Text] [Related]

  • 30. Comparison of two analytical platforms for the clinical qualification of Alzheimer's disease biomarkers in pathologically-confirmed dementia.
    Le Bastard N, Coart E, Vanderstichele H, Vanmechelen E, Martin JJ, Engelborghs S.
    J Alzheimers Dis; 2013 Jul; 33(1):117-31. PubMed ID: 22936010
    [Abstract] [Full Text] [Related]

  • 31. [A new approach to the Alzheimer's disease diagnosis with biomarkers: description of the AD-CSF-Index].
    Molinuevo JL, Gispert JD, Pujol J, Rojas S, Lladó A, Balasa M, Antonell A, Sánchez-Valle R, Rami L.
    Rev Neurol; 2012 May 01; 54(9):513-22. PubMed ID: 22532214
    [Abstract] [Full Text] [Related]

  • 32. Concentrations of metals, beta-amyloid and tau-markers in cerebrospinal fluid in patients with Alzheimer's disease.
    Gerhardsson L, Blennow K, Lundh T, Londos E, Minthon L.
    Dement Geriatr Cogn Disord; 2009 May 01; 28(1):88-94. PubMed ID: 19672066
    [Abstract] [Full Text] [Related]

  • 33. Association of 1H-MR spectroscopy and cerebrospinal fluid biomarkers in Alzheimer's disease: diverging behavior at three different brain regions.
    Bittner DM, Heinze HJ, Kaufmann J.
    J Alzheimers Dis; 2013 May 01; 36(1):155-63. PubMed ID: 23579327
    [Abstract] [Full Text] [Related]

  • 34. Measurement of phosphorylated tau epitopes in the differential diagnosis of Alzheimer disease: a comparative cerebrospinal fluid study.
    Hampel H, Buerger K, Zinkowski R, Teipel SJ, Goernitz A, Andreasen N, Sjoegren M, DeBernardis J, Kerkman D, Ishiguro K, Ohno H, Vanmechelen E, Vanderstichele H, McCulloch C, Moller HJ, Davies P, Blennow K.
    Arch Gen Psychiatry; 2004 Jan 01; 61(1):95-102. PubMed ID: 14706948
    [Abstract] [Full Text] [Related]

  • 35. [Neuro-specific enolase in acute ischemic stroke and related dementia patients].
    Fang D, Li Y, Wang X, Yang Z.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1995 Dec 01; 17(6):439-42. PubMed ID: 9208570
    [Abstract] [Full Text] [Related]

  • 36. Elevated cerebrospinal fluid tau protein levels in Wernicke's encephalopathy.
    Matsushita S, Miyakawa T, Maesato H, Matsui T, Yokoyama A, Arai H, Higuchi S, Kashima H.
    Alcohol Clin Exp Res; 2008 Jun 01; 32(6):1091-5. PubMed ID: 18445112
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Structural biomarkers in the cerebrospinal fluid within 24 h after a traumatic spinal cord injury: a descriptive analysis of 16 subjects.
    Pouw MH, Kwon BK, Verbeek MM, Vos PE, van Kampen A, Fisher CG, Street J, Paquette SJ, Dvorak MF, Boyd MC, Hosman AJ, van de Meent H.
    Spinal Cord; 2014 Jun 01; 52(6):428-33. PubMed ID: 24710150
    [Abstract] [Full Text] [Related]

  • 39. Cerebrospinal fluid neuron-specific enolase in non-selected patients.
    Finsterer J, Exner M, Rumpold H.
    Scand J Clin Lab Invest; 2004 Jun 01; 64(6):553-8. PubMed ID: 15370460
    [Abstract] [Full Text] [Related]

  • 40. Evaluation of cerebrospinal fluid tau/beta-amyloid(42) ratio as diagnostic markers for Alzheimer disease.
    Smach MA, Charfeddine B, Ben Othman L, Lammouchi T, Dridi H, Nafati S, Ltaief A, Bennamou S, Limem K.
    Eur Neurol; 2009 Jun 01; 62(6):349-55. PubMed ID: 19786779
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.